PB2250: GENETIC REGULATION IN IRON OMEOSTASIS IN SIDEROPENIC COVID19 DISEASE AFFECTED PATIENTS WITH NEW IRON ORAL FORMULATION: LESSONS FROM A DIFFERENT PERSPECTIVE
Main Authors: | G. giordano, L. alessandro, M. napolitano |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000851828.02583.3b |
Similar Items
-
Coeliac disease as the cause of resistant sideropenic anaemia in children with Down's syndrome: Case report
by: Pavlović Momčilo, et al.
Published: (2010-01-01) -
PB2249: SUCROSOMIAL IRON SUPPORT IN PATIENT WITH IRON DEFICIENCY ANEMIA IS HIGLY EFFECTIVE IN IMPROVING ANEMIA REDUCING ERYPTOSIS AND M1 MACROPHAGES POLARIZATION
by: G. giordano, et al.
Published: (2022-06-01) -
PB2250: THE IMPACT OF JAK2V617F MUTATION POSITIVITY IN ESSENTIAL THROMBOCYTHEMIA:ABOUT 74 CASES.
by: Arij Cheffai, et al.
Published: (2023-08-01) -
Improvement in 100-m Sprint Performance at an Altitude of 2250 m
by: Nicholas P. Linthorne
Published: (2016-05-01) -
Advances in Iron Chelation Therapy: Towards A New Oral Formulation
by: Farid Ghazizadeh, et al.
Published: (2022-07-01)